FindTrial
Sign In

Excimer Laser Ablation Combined with Drug-Coated Balloon versus Drug-Coated Balloon in the tReatment of AThErosclerotic Lesions in Lower Extremities

Excimer Laser Ablation Combined with Drug-Coated Balloon versus Drug-Coated Balloon in the tReatment of AThErosclerotic Lesions in Lower Extremities

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051263
Enrollment
Unknown
Registered
2021-09-17
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerotic obliterans

Interventions

Group one:excimer laser ablation+drug-coated balloon
Group two:drug-coated balloon

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Male or female aged >=18 years; 2. The length of femoral popliteal and inferior knee artery lesions is less than or equal to 10cm; 3. Lesion stenosis >= 70% or completely occlusive disease; 4. Rutherford Grades 2-5.

Exclusion criteria

Exclusion criteria: 1. In-stent restenosis lesions; 2. Acute thrombotic lesions; 3. Use other volume reduction devices at the same time for target lesions; 4. Severe renal insufficiency (creatinine > 250umol/L, non-dialysis state), contrast agent allergy, coagulation dysfunction, etc. cannot tolerate surgery.

Design outcomes

Primary

MeasureTime frame
primary patency;clinically driven target lesion reintervention;technical success;ulcer healing;major adverse event;—

Countries

China

Contacts

Public ContactDong Zhihui

Zhongshan Hospital, Fudan University

dzh926@126.com+86 13564249168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026